Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

Shapiro, R and Jordan, ML and Scantlebury, VP and Vivas, C and Gritsch, HA and Corry, RJ and Egidi, F and McCauley, J and Ellis, D and Gilboa, N (1995) The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. Clinical transplants. 199 - 205. ISSN 0890-9016

[img]
Preview
PDF
Accepted Version
Available under License : See the attached license file.

Download (1MB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

Tacrolimus is a superior immunosuppressive agent in patients undergoing renal transplantation. In adults, the 1- and 3-year actuarial patient survivals were 95% and 92%, and the 1- and 3-year actuarial graft survivals were 89% and 80%. For first cadaver kidneys, the 1- and 3-year actuarial graft survivals were 91% and 82%, with a projected half-life of 11.9 years. Sixty-nine percent of successfully transplanted patients were weaned off steroids. In pediatric patients, the 1- and 4-year actuarial patient survivals were 100% and 96%, and the 1- and 4-year actuarial graft survivals were 99% and 85%. Seventy-three percent of successfully transplanted children were weaned off steroids. Tacrolimus was also useful as a rescue agent, with an initial success rate of 74%. Tacrolimus has been used successfully in kidney/ pancreas transplantation, with 100% patient, 95% kidney, and 79% pancreas graft survival. Tacrolimus should be considered the immunosuppressive agent of choice in renal transplantation.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Shapiro, R
Jordan, ML
Scantlebury, VP
Vivas, C
Gritsch, HA
Corry, RJ
Egidi, F
McCauley, J
Ellis, D
Gilboa, N
Centers: Other Centers, Institutes, Offices, or Units > Thomas E. Starzl Transplantation Institute
Date: 1 January 1995
Date Type: Publication
Journal or Publication Title: Clinical transplants
Page Range: 199 - 205
Institution: University of Pittsburgh
Refereed: Yes
ISSN: 0890-9016
Article Type: Review
Other ID: uls-drl:31735062133164, Starzl CV No. 1852
PubMed ID: 8794266
Date Deposited: 08 Apr 2010 17:31
Last Modified: 08 Feb 2019 15:55
URI: http://d-scholarship.pitt.edu/id/eprint/5238

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item